Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Contract drugmaking on fast growth track
Fierce Pharma
Tuesday, December 22, 2009 - 4:10pm
tags:
contract drug manufacturing
FDA Says 'Unlikely' That Vytorin, Zetia Increase Cancer Risk
WSJ Online
Tuesday, December 22, 2009 - 4:09pm
tags:
Vytorin, Zetia, cancer, FDA
Human Genome Sciences Looks Ready to Break Out
Seeking Alpha
Tuesday, December 22, 2009 - 9:37am
tags:
Human Genome Sciences
OSI Pharmaceuticals trims 2010 revenue outlook
Yahoo/AP
Tuesday, December 22, 2009 - 9:36am
tags:
OSI Pharmaceuticals, earnings, outlook
Lupin Settles Litigation With Forest For Namenda Tablets
WSJ Online
Tuesday, December 22, 2009 - 9:34am
tags:
Forest Labs, Namenda, Lupin, settlements, generics
AstraZeneca Is ‘More Sensitive’ About Illegal Marketing
Pharmalot
Tuesday, December 22, 2009 - 9:32am
tags:
AstraZeneca, off-label
Arena submits U.S. application for obesity drug
Marketwatch
Tuesday, December 22, 2009 - 9:31am
tags:
obesity, Arena Pharmaceuticals
[video]Healthy Drug Deals
Yahoo/TheStreet.com
Tuesday, December 22, 2009 - 9:29am
tags:
Sanofi, Chattem, Pfizer, M&A
QLT Inc. establishes sales force in the United States
Yahoo
Tuesday, December 22, 2009 - 8:08am
tags:
QLT, Visudyne
Obituaries II: Metabasis Hit by Perfect Storm of Failed Products, Partnerships, Economy
BNET Pharma
Tuesday, December 22, 2009 - 8:07am
tags:
Metabasis
Roche, Genentech try to calm jittery partners
Fierce Biotech
Tuesday, December 22, 2009 - 8:06am
tags:
Roche, Genentech, M&A
FDA extends decision on Cephalon’s Nuvigil for jet lag
Bizjournals.com
Tuesday, December 22, 2009 - 7:59am
tags:
FDA, Cephalon, jet lag, NUVIGIL
Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
Yahoo
Tuesday, December 22, 2009 - 7:57am
tags:
Vytorin, patents, Mylan, Schering Plough
Abbott Sues Sandoz Over Patent for Muscle Relaxant Nimbex
Bloomberg
Tuesday, December 22, 2009 - 7:55am
tags:
Abbott Laboratories, muscle relaxants, Nimbex, Sandoz, lawsuits
Obesity Becomes Shionogi’s Gamble for Another Crestor
Bloomberg
Tuesday, December 22, 2009 - 7:53am
tags:
Crestor, obesity, Shionogi, Velneperit
Lilly licenses PDL type 1 diabetes drug candidate
Yahoo/AP
Tuesday, December 22, 2009 - 7:52am
tags:
type 1 diabetes, Eli Lilly, licensing, PDL Biopharma, teplizumab
Sanofi's Allegra Gambit
Forbes
Tuesday, December 22, 2009 - 7:51am
tags:
Allegra, Sanofi
Rigel Pharma Gives Up Gains
Barron's
Tuesday, December 22, 2009 - 7:50am
tags:
Rigel
Amgen Closer to Prolia Approval
Yahoo/Zacks.com
Monday, December 21, 2009 - 5:21pm
tags:
Amgen, Prolia
CombinatoRx and Neuromed Close Merger
Yahoo
Monday, December 21, 2009 - 4:19pm
tags:
M&A, Neuromed, CombinatoRx

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.